Home » Topics » Regulatory

Regulatory
RSS

Clomethiazole: use in spinal cord injury

Jan. 18, 2000

European Commission approves new indication for AstraZeneca antiasthmatic

Jan. 17, 2000

FDA accepts NDA for new Rapamune formulation

Jan. 14, 2000

Once-daily antidiabetic drug from Andrx steadily advances towards market launch

Jan. 11, 2000

New combination therapy for depression with reduced side effects

Jan. 11, 2000

Pharmacia & Upjohn seeks approval for combination glaucoma therapy

Jan. 11, 2000

FDA approves liquid formulation of Celexa for treatment of depression

Jan. 10, 2000

The antiplatelet agent triflusal now shown to inhibit NF-kappaB activation

Jan. 10, 2000

Olanzapine and fluoxetine in combination useful for refractory depression

Jan. 10, 2000

Miltefosine tested as oral treatment for leishmaniasis

Jan. 4, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...